Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Daniel Koller
Felicia Flanigan
Board:
Clive Meanwell
Mads Krogsgaard Thomsen
Pearl Shirley Huang
Camilla Soenderby
Laura Hamill
Thomas von Planta
Shareholding in %:
BB Biotech AG 1
BlackRock Asset Management Schweiz AG 0.2
Border to Coast Pensions Partnership Ltd. 0.41
Credit Suisse Asset Management (Schweiz) AG 1.63
Erich Hunziker 1.73
Pictet Asset Management SA 0.27
UBS Asset Management Switzerland AG 1.34
Union Bancaire Privée, UBP SA 0.32
Vontobel Asset Management AG 0.39
Zürcher Kantonalbank (Investment Management) 1.72
Freefloat 90.98
Address: Schwertstrasse 6, 8200 Schaffhausen
T: +41-52-624-08-45
F: +
I: http://www.bbbiotech.com
E: info@bbbiotech.com